IL112992A0 - Recombinant viruses, their preparation and their use in gene therapy - Google Patents

Recombinant viruses, their preparation and their use in gene therapy

Info

Publication number
IL112992A0
IL112992A0 IL11299295A IL11299295A IL112992A0 IL 112992 A0 IL112992 A0 IL 112992A0 IL 11299295 A IL11299295 A IL 11299295A IL 11299295 A IL11299295 A IL 11299295A IL 112992 A0 IL112992 A0 IL 112992A0
Authority
IL
Israel
Prior art keywords
preparation
gene therapy
recombinant viruses
viruses
recombinant
Prior art date
Application number
IL11299295A
Other languages
English (en)
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of IL112992A0 publication Critical patent/IL112992A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL11299295A 1994-03-18 1995-03-14 Recombinant viruses, their preparation and their use in gene therapy IL112992A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9403191A FR2717496B1 (fr) 1994-03-18 1994-03-18 Virus recombinants, préparation et utilisation en thérapie génique.

Publications (1)

Publication Number Publication Date
IL112992A0 true IL112992A0 (en) 1995-06-29

Family

ID=9461190

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11299295A IL112992A0 (en) 1994-03-18 1995-03-14 Recombinant viruses, their preparation and their use in gene therapy

Country Status (12)

Country Link
EP (1) EP0750676A1 (fi)
JP (1) JPH09510358A (fi)
KR (1) KR970701784A (fi)
AU (1) AU703793B2 (fi)
CA (1) CA2184200A1 (fi)
FI (1) FI963674A0 (fi)
FR (1) FR2717496B1 (fi)
IL (1) IL112992A0 (fi)
MX (1) MX9603490A (fi)
NO (1) NO963559L (fi)
WO (1) WO1995025804A1 (fi)
ZA (1) ZA952244B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830857A (en) * 1995-07-14 1998-11-03 Amgen Inc. Method of treating epilepsy
FR2753379B1 (fr) 1996-09-13 1998-10-30 Rhone Poulenc Rorer Sa Methode de traitement de la sclerose laterale amyotrophique
DE60137414D1 (de) * 2000-05-05 2009-03-05 Univ City Zusammensetzungen zur stimulierung der regeneration und der wiederherstellung des nervensystems durch regulierung der arginase 1- und polyamin-synthese
WO2019162942A1 (en) * 2018-02-20 2019-08-29 Carmel Haifa University Economic Corporation Ltd. Compositions and methods for delivery and expression of small inhibitory peptides and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2113083A1 (en) * 1991-07-10 1993-01-21 Vivien Wong Methods of treatment of motor neuron diseases using members of the bdnf/nt-3/ngf family of molecules
US5733871A (en) * 1991-11-08 1998-03-31 The General Hospital Corporation Methods for the treatment of neuronal damage associated with ischemia, hypoxia or neurodegeneration
FR2688514A1 (fr) * 1992-03-16 1993-09-17 Centre Nat Rech Scient Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
AU4995193A (en) * 1992-08-04 1994-03-03 Regeneron Pharmaceuticals, Inc. Method of enhancing differentiation and survival of neuronal precursor cells
DE69334238D1 (de) * 1992-09-25 2008-09-25 Aventis Pharma Sa Adenovirus vektoren für die übertragung fremder gene in zellen des zentralen nervensystems, insbesondere im gehirn
FR2704234B1 (fr) * 1993-04-22 1995-07-21 Centre Nat Rech Scient Virus recombinants, preparation et utilisation en therapie genique.

Also Published As

Publication number Publication date
CA2184200A1 (fr) 1995-09-28
FI963674A (fi) 1996-09-17
FR2717496A1 (fr) 1995-09-22
FR2717496B1 (fr) 1996-04-12
MX9603490A (es) 1997-03-29
AU1896295A (en) 1995-10-09
ZA952244B (en) 1996-01-16
NO963559L (no) 1996-08-26
KR970701784A (ko) 1997-04-12
FI963674A0 (fi) 1996-09-17
AU703793B2 (en) 1999-04-01
EP0750676A1 (fr) 1997-01-02
WO1995025804A1 (fr) 1995-09-28
JPH09510358A (ja) 1997-10-21

Similar Documents

Publication Publication Date Title
ZA949104B (en) Recombinant viruses and their use in gene therapy
ZA951803B (en) Recombinant viruses their preparation and their therapeutic use
ZA952563B (en) Recombinant viruses their preparation and their use in gene therapy
IL115584A0 (en) Viral vectors and their use in gene therapy
HUP9801216A3 (en) Dna molecules, preparation thereof and use thereof in gene therapy
HUP9802217A3 (en) Recombinant mva virus, and the use thereof
EP0710667A3 (de) Modifizierte Oligonukleotide, deren Herstellung sowie deren Verwendung
AU4032893A (en) Human papilloma virus genes and their use in gene therapy
ZA979096B (en) Viral and cancer treatment
HU9503751D0 (en) Antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection
ZA945012B (en) Viral vectors and their use in gene therapy
IL111682A0 (en) Recombinant viruses and their use in gene therapy
AU4556597A (en) Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
HUP9901035A3 (en) Parapoxviruses containing foreign dna, their production and their use in vaccines
HUP9903886A3 (en) Azacycloalcane derivatives, preparation thereof and their applications in therapy
ZA961998B (en) Recombinant viruses expressing lecithin-cholesterol acyl-transferase and their use in gene therapy
IL112075A0 (en) Recombinant human thymopoietin proteins, their preparation and their medicinal use
ZA952242B (en) Recombinant viruses their preparation and their use in gene therapy
AU9269898A (en) Artificial viruses derived from papillomavirus, and their uses, in particular gene therapy
ZA978772B (en) N-(2-benzothiazolyl)-1-piperidineethanamine derivatives, their preparation and their use in therapy.
IL112992A0 (en) Recombinant viruses, their preparation and their use in gene therapy
ZA959904B (en) Iminooxymethyleneanilides thei preparation and their use
IL133536A0 (en) 6-pyrrolidin-2-ylpyridine derivatives, their preparation and application in therapy
IL112994A0 (en) Recombinant viruses, their preparation and their use in gene therapy
ZA952286B (en) Recombinant viruses their preparation and their use in gene therapy